Day: February 24, 2026

Results in a population of 278 patients affirm statistically significant mortality reductions Benefits observed across severity groups and in subjects with serious comorbidities Company files provisional patent applications for sepsis, acute kidney injury and pneumonia Strategic collaborations to support late-stage development and commercialization being evaluated Study results selected for oral presentation at ATS 2026 conferenceTORONTO, Feb. 24, 2026 (GLOBE NEWSWIRE) — Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today positive additional data from a Phase 3 study of paridiprubart. The results represent a broader, 278-patient population, which includes both previously reported 104 patients requiring...

Netanya, Israel, Feb. 24, 2026 (GLOBE NEWSWIRE) — Silynxcom Ltd. (NYSE American: SYNX) (“Silynxcom” or the “Company”), a manufacturer and developer of ruggedized tactical communication headset devices, today announced the receipt of two new purchase orders from first-response units in two European countries. The first order is a repeat purchase from a police department in Europe. This customer has previously acquired and is actively using the Company’s advanced tactical headset systems and related communication accessories.. The second order comes from a fire department in Europe. This department will deploy the Company’s rugged tactical communication equipment to enable clear and reliable communication in high-risk environments and complex rescue operations. We believe that these new orders reflect the growing adoption of Silynxcom’s...

14:15 London, 16:15 Helsinki, 24 February 2026 – Afarak Group SE (“Afarak” or “the Company”) (LSE: AFRK, NASDAQ: AFAGR) PROFIT WARNING – DECREASE IN EBITDA Stock Exchange Release The Board of Directors of Afarak Group SE (“Company”) estimates that despite higher revenue of 141.3 million Euro, EBITDA for the full year 2025 is at approximately 0.7 million Euro, compared to 2.6 million Euro in 2024. In the Interim financial release H1 2025 published on 15th August 2025, the Company stated the following expectations. We wish to provide our shareholders with an update on these: OUTLOOK FOR THE SECOND HALF OF 2025 The market for standard grade low carbon ferro-chrome is expected to be stable throughout the year with some modest upwards potential. The weak US$ could easily wipe out any price increases, and cheap...

Collaboration powers secure international data sharing through the HiFi Solves Global Consortium MENLO PARK, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced a collaboration with DNAstack to power the world’s first global federated dataset of HiFi whole genome sequencing data. Through the HiFi Solves Global Consortium, the collaboration enables secure international research — allowing genomic insights to travel across borders while sensitive data remains under institutional control. Participating institutions connect HiFi whole genome sequencing data and associated metadata within a highly secure federated environment. Hosted by DNAstack and accessible at https://hifisolves.org, the platform enables researchers to query harmonized datasets...

New real-time AI solution for in-store teams makes rapid recommendations for deals, add-ons, and savings for a more efficient customer experience  SoundHound processed nearly 30 million AI customer interactions telecom and retail businesses globally in 2025; Debuts at MWC Barcelona as part of growing interest from European marketSANTA CLARA, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) — SoundHound AI, Inc. (Nasdaq: SOUN), a global leader in voice and conversational AI, today announced the launch of Sales Assist, a new voice-powered AI agent for retail which will debut at Mobile World Congress 2026 (Hall 7, Booth 7E40). The revolutionary in-store agent builds on SoundHound’s existing AI offerings for enterprise businesses, including the company’s next-generation agentic AI platform. Agentic AI on the Sales Floor Designed for in-store...

MINNEAPOLIS, Feb. 24, 2026 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced a strategic data licensing agreement with Risorius Co., Ltd., a neurotechnology company developing EEG-based digital biomarkers and AI-powered research platforms for central nervous system (CNS) indications across neurology, psychiatry, and sleep. This new relationship supports OneMedNet’s continued focus on expanding its base of subscription contracts, adding multi-year agreements that represent millions of dollars in incremental recurring revenue. The agreement was executed in record time following the companies’ initial meeting, reflecting strong commercial alignment, clear product-market fit, and immediate value to the customer. Data delivery is now underway...

Wix Launches Integration With Google Search, Google Maps and Google AI ModeWix Launches Integration With Google Search, Google Maps and Google AI Mode to Turn Queries Into Instant Bookings on WebWix Launches Integration With Google Search, Google Maps and Google AI ModeWix Launches Integration With Google Search, Google Maps and Google AI Mode to Turn Queries Into Instant Bookings on MobileNew Wix Bookings integration syncs services, pricing and near real-time availability into Google’s new agentic commerce offerings enabling service businesses to capture demand directly from search results NEW YORK – Wix.com Ltd. (NASDAQ: WIX), a leading global platform for creating, managing and growing a complete digital presence, today announced an integration between Wix Bookings and Google Search, Google Maps and Google AI Mode....

CARLSBAD, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended December 31, 2025, before the market opens on Tuesday, March 10, 2026. John Aballi, President and Chief Executive Officer, and Jeff Black, Chief Financial Officer, will host a conference call to review the company’s results at 8:30 a.m. ET (5:30 a.m. PT). Conference Call & Webcast:U.S. dial-in: 877-407-0890 International dial-in: +1 201-389-0918 Webcast: Available via the Exagen investor relations website at investors.exagen.comReplay: A telephone replay will be available until Tuesday, March 24, 2026:U.S. replay: 877-660-6853 International replay: +1 201-612-7415 Replay passcode: 13757484 Webcast: A recording of the webcast will be available...

NOT FOR DISTRIBUTION TO U.S NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, Feb. 24, 2026 (GLOBE NEWSWIRE) — Opus One Gold Corp (TSX-V: OOR) (the “Company” or “Opus One”) is pleased to present positive results obtained from a Laser Induced Breakdown Spectrometry (LIBS) study from ECORE (ELEMISSION LIBS technology) on drill core recovered during its winter 2025 drilling project on Zone 1 on its 100% owned Noyell gold project, Abitibi, Quebec. This study is part of a metallurgical evaluation program aimed at acquiring a better understanding of Zone 1 gold association with other metals and minerals. Opus One received the results of a ECORE study carried out on mineralized core from holes NO-25-07 and NO-25-13. The former is a relatively shallow hole while the latter represents the deepest high-grade interval...

Company Highlights Advanced Partnering Discussions as AD04 Advances Toward Phase 3 GLEN ALLEN, Va., Feb. 24, 2026 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that it received notice from Nasdaq on February 23, 2026, that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). Nasdaq determined that for the last 10 consecutive business days, from February 6 through February 20, 2026, the closing bid price of the Company’s common stock has been at $1.00 per share or greater. The Company has now successfully resolved its Nasdaq compliance issue and Nasdaq has...